ALN-4324
/ Alnylam
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
April 02, 2025
A Phase 1 Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=84 | Recruiting | Sponsor: Alnylam Pharmaceuticals | Not yet recruiting ➔ Recruiting
Enrollment open • Obesity
February 26, 2025
A Phase 1 Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=84 | Not yet recruiting | Sponsor: Alnylam Pharmaceuticals
New P1 trial • Obesity
1 to 2
Of
2
Go to page
1